Background: Managing pocket infections in cardiac implantable electronic devices (CIEDs) during early pregnancy presents significant clinical challenges, as current guidelines mandate complete system extraction. However, extraction carries high maternal-fetal risks, including surgical complications, radiation exposure, and teratogenic effects of systemic antibiotics.
Case Summary: A 29-year-old woman, 5-week pregnant, was referred for a CIED pocket infection with an extruding implantable cardioverter-defibrillator implanted 9 years earlier for idiopathic ventricular fibrillation.
Background: Waitlists for transcatheter aortic valve replacement (TAVR) are increasingly growing, universal criteria for prioritizing candidates are lacking, and some patients experience adverse events while awaiting the procedure. Aortic stenosis (AS)-related cardiac damage (CD) staging provides an echocardiographic framework for assessing structural CD in AS patients. We aimed to assess the correlation between CD staging and AS-related adverse events in patients awaiting TAVR.
View Article and Find Full Text PDFBackground: In contrast to left bundle branch block, right bundle branch block (RBBB) is rare after transcatheter aortic valve replacement (TAVR).
Objectives: This study sought to define the incidence of post-TAVR new-onset RBBB and the risk factors associated with permanent pacemaker implantation (PPI) need.
Methods: Data from 7,782 consecutive TAVR procedures performed in 7 Israeli centers were retrospectively analyzed.
Background: Left ventricular (LV) end-systolic enlargement in severe degenerative mitral-regurgitation (MR) is a class I surgical trigger. Whether it occurs disproportionately to less-than-severe MR due to mitral valve prolapse and is associated with mortality are unknown. We aimed to analyze prevalence and association with survival of disproportionate LV enlargement in less-than-severe MR.
View Article and Find Full Text PDFIntroduction: Everolimus (EVR)-induced kidney injury is rarely reported. Conversely, acute tubular necrosis (ATN) is a recognized complication of high-dose bisphosphonate therapy.
Case Presentation: SM, a 69-year-old female patient with advanced breast cancer, developed severe kidney injury necessitating renal replacement therapy (RRT) shortly after initiating EVR treatment, while concurrently receiving chronic high-potency bisphosphonate therapy.
Background: The management of Transcatheter Aortic Valve Implantation (TAVI) patients with a small aortic annulus (SAA) postures a substantial challenge, increasing the risk of patient- prosthesis mismatch (PPM) and overall mortality.
Aims: This study aimed to compare the hemodynamic and clinical outcomes of transcatheter balloon-expandable valve (BEV) versus transcatheter self-expandable valve (SEV) in SAA.
Methods: We conducted propensity score matching (PSM) of severe AS patients with SAA who underwent trans-femoral TAVR and enrolled to the Israeli TAVR registry between the years 2008 and 2023.
Background: Limited observational reports link elevated lipoprotein(a) (Lp[a]) levels to aortic stenosis (AS) or to disease progression. Data on large cohorts of verified severe AS patients are lacking.
Objectives: The purpose of the study was to characterize Lp(a) levels of severe AS patients referred to transcatheter aortic valve implantation (TAVI) and compare them to a large cohort of Lp(a) samples derived from the general population.
Background: The ACURATE neo2 transcatheter aortic valve was developed to improve paravalvular leak (PVL) rates while maintaining low rates of conduction disturbances and permanent pacemaker implantation (PPMI) seen with its predecessor. We aimed to compare conduction disturbances rates of transcatheter aortic valve replacement (TAVR) using ACURATE Neo2 with other commonly used valves.
Methods: A retrospective analysis of the Israeli TAVR registry between the years 2014-2023 was performed to compare conduction disturbances and PVL rates, and procedural outcomes, among patients treated with ACURATE neo2, Edwards Sapien 3 (S3), and Evolut PRO valves.
JACC Cardiovasc Interv
March 2024
JACC Cardiovasc Interv
September 2022
Background: Despite advances in transcatheter aortic valve replacement (TAVR), periprocedural acute ischemic stroke remains a concern.
Objectives: The aims of this study were to investigate acute ischemic stroke complicating TAVR (AISCT) and to describe the indications and outcomes of interventions to treat AISCT.
Methods: An international multicenter registry was established focusing on AISCT within 30 days of TAVR.
Background: Implantation of drug eluting stents (DES) is the mainstay treatment for patients requiring percutaneous coronary intervention (PCI). The polymer coating of DES has been associated with inflammatory response, increased arterial injury and long-term in-stent restenosis and thrombosis. Polymer-free stents (PFS) were designed to overcome limitations of polymer-coated stents (PCS).
View Article and Find Full Text PDFJ Am Soc Echocardiogr
July 2021
Introduction: Elevated plasma levels of neutrophil gelatinase-associated lipocalin (NGAL) is a marker of tubular damage and aid in the early identification of acute kidney injury (AKI). We evaluated NGAL levels for identification of AKI superimposed on chronic kidney disease (CKD) vs. "de novo" AKI among ST elevation myocardial infarction (STEMI) patients undergoing primary coronary intervention (PCI).
View Article and Find Full Text PDFIsr Med Assoc J
July 2020
Int J Cardiovasc Imaging
October 2020